0001209191-21-045418.txt : 20210706 0001209191-21-045418.hdr.sgml : 20210706 20210706161202 ACCESSION NUMBER: 0001209191-21-045418 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20210630 FILED AS OF DATE: 20210706 DATE AS OF CHANGE: 20210706 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: KING RICHARD CENTRAL INDEX KEY: 0001013702 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-39594 FILM NUMBER: 211074195 MAIL ADDRESS: STREET 1: C/O KOS PHARMACEUTICALS INC STREET 2: 1001 BRICKELL AVE 25TH FL CITY: MIAMI STATE: FL ZIP: 33131 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: SPRUCE BIOSCIENCES, INC. CENTRAL INDEX KEY: 0001683553 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 812154263 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 2001 JUNIPERO SERRA BLVD., SUITE 640 CITY: DALY CITY STATE: CA ZIP: 94104 BUSINESS PHONE: (415) 294-1687 MAIL ADDRESS: STREET 1: 2001 JUNIPERO SERRA BLVD., SUITE 640 CITY: DALY CITY STATE: CA ZIP: 94104 4 1 doc4.xml FORM 4 SUBMISSION X0306 4 2021-06-30 0 0001683553 SPRUCE BIOSCIENCES, INC. SPRB 0001013702 KING RICHARD 2001 JUNIPERO SERRA BOULEVARD, SUITE 640 DALY CITY CA 94014 1 1 0 0 Chief Executive Officer Common Stock 2021-06-30 5 J 0 E 2230 9.5285 A 2230 D Shares acquired by Mr. King pursuant to the Issuer's 2020 Employee Stock Purchase Plan in a transaction that was exempt under both Rule 16b-3(d) and Rule 16b-3(c). /s/ Samir Gharib, Attorney-in-Fact 2021-07-06